Self-Assembled Peptide PROTAC Prodrugs Targeting FOXM1 for Cancer Therapy

Huajie Zeng(Fujian Medical University), Zihua Wang(Fujian Medical University), Weibing Miao(Fujian Medical University), Tong Su(Fujian Medical University), Zhiguo Fang(Center for NanoScience), Yinghua Feng(Shanxi Medical University)

Molecular Pharmaceutics

May 14, 2025

10.1021/acs.molpharmaceut.5c00219

Cited by 9

Related Papers

Biomimetic Nanovesicles as a Dual Gene Delivery System for the Synergistic Gene Therapy of Alzheimer’s Disease

|ACS Nano|2024|109

Oxyhaemoglobin saturation NIR-IIb imaging for assessing cancer metabolism and predicting the response to immunotherapy

|Nature Nanotechnology|2023|70

Fibroblast Activation Protein‐α Responsive Peptide Assembling Prodrug Nanoparticles for Remodeling the Immunosuppressive Microenvironment and Boosting Cancer Immunotherapy

|Small|2021|46

Novel Peptide-Based Magnetic Nanoparticle for Mesenchymal Circulating Tumor Cells Detection

|Analytical Chemistry|2021|44

Glioblastoma cell-derived exosomes functionalized with peptides as efficient nanocarriers for synergistic chemotherapy of glioblastoma with improved biosafety

|Nano Research|2023|31